Non-nucleoside reverse transcriptase inhibitors

PK201100219A0Undetermined Publication Date: 2011-04-12MERCK CANADA INC
0 Cites 0 Cited by

Patent Information

Application Number
PK201100219
Authority / Receiving Office
PK · PK
Patent Type
Applications
Current Assignee / Owner
Filing Date
2011-03-28
Publication Date
2011-04-12
Patent Text Reader

Abstract

Heteroaromatic compounds of Formula I:are HIV reverse transcriptase inhibitors, wherein R 1 , R2 , R3 , R4 and R5 are defined herein. The compounds of Formula I are useful in the inhibition of HIV reverse transcriptase, the prophylaxis and treatment of infection by HIV and in the prophylaxis, delay in the onset or progression, and treatment of AIDS. The compounds and their salts can be employed as ingredients in pharmaceutical compositions, optionally in combination with other antivirals, immunomodulators, antibiotics or vaccines.
Need to check novelty before this filing date? Find Prior Art